Anticancer therapy with HDAC inhibitors: mechanism-based combination strategies and future perspectives

R Jenke, N Reßing, FK Hansen, A Aigner, T Büch - Cancers, 2021 - mdpi.com
Simple Summary Beyond mutations, epigenetic changes have been described as drivers for
cancer as well. While leaving the overall DNA structure intact, they can be responsible for …

A review of progress in histone deacetylase 6 inhibitors research: structural specificity and functional diversity

XH Zhang, Qin-Ma, HP Wu, MY Khamis… - Journal of medicinal …, 2021 - ACS Publications
Histone deacetylases (HDACs) are essential for maintaining homeostasis by catalyzing
histone deacetylation. Aberrant expression of HDACs is associated with various human …

Dual inhibitors of histone deacetylases and other cancer-related targets: A pharmacological perspective

Y Gao, H Zhang, F Lirussi, C Garrido, XY Ye… - Biochemical …, 2020 - Elsevier
Epigenetic enzymes histone deacetylases (HDACs) are clinically validated anticancer drug
targets which have been studied intensively in the past few decades. Although several drugs …

Pan-and isoform-specific inhibition of Hsp90: Design strategy and recent advances

J Yu, C Zhang, C Song - European Journal of Medicinal Chemistry, 2022 - Elsevier
In the past few decades, the development of heat shock protein 90 (Hsp90) inhibitors for
cancer treatment has not stopped. About twenty compounds have been evaluated in the …

Small-molecule dual inhibitors targeting heat shock protein 90 for cancer targeted therapy

X Xie, N Zhang, X Li, H Huang, C Peng, W Huang… - Bioorganic …, 2023 - Elsevier
Heat shock protein 90, also known as Hsp90, is an extensively preserved molecular
chaperone that performs a critical function in organizing various biological pathways and …

[HTML][HTML] Discovery of potent pyrrolo-pyrimidine and purine HDAC inhibitors for the treatment of advanced prostate cancer

D Moi, D Bonanni, S Belluti, P Linciano… - European Journal of …, 2023 - Elsevier
The development of drugs for the treatment of advanced prostate cancer (PCA) remains a
challenging task. In this study we have designed, synthesized and tested twenty-nine novel …

Antifungal Activity and DNA Topoisomerase Inhibition of Hydrolysable Tannins from Punica granatum L.

V Brighenti, R Iseppi, L Pinzi, A Mincuzzi… - International Journal of …, 2021 - mdpi.com
Punica granatum L.(pomegranate) fruit is known to be an important source of bioactive
phenolic compounds belonging to hydrolysable tannins. Pomegranate extracts have shown …

[HTML][HTML] Oxadiazole derivatives: Histone deacetylase inhibitors in anticancer therapy and drug discovery

BW Matore, P Banjare, T Guria, PP Roy… - European Journal of …, 2022 - Elsevier
Heterocycles are being playing an important role in cancer treatment for years. Currently, a
number of anticancer agents are available on market, but concerns such as less …

Design, synthesis, and biological evalution of bifunctional inhibitors against Hsp90-HDAC6 interplay

HY Chae, SY Park, S Jha, SK Gupta, M Kim… - European journal of …, 2022 - Elsevier
HDAC6 and Hsp90, existing as a cytosolic complex play an important role in maintaining the
protein homeostasis. The interplay of HDAC6 and Hsp90 has attracted wide attention due to …

Co (II), Ni (II), and Zn (II) complexes of 5‐methyl‐1, 3, 4‐oxadiazol‐2‐amine Schiff base as potential heat shock protein 90 inhibitors: Spectroscopic, biological activity …

AS Al‐Janabi, AFK Al‐Bayati, OA ALtaie… - Applied …, 2022 - Wiley Online Library
Heat shock protein 90 (Hsp90) is a promising target in tumor biology as required for
oncogenic protein kinases. The Hsp90‐alpha N‐domain delineates an ATP binding pocket; …